I am going to call Steve at Amarin's IR department this afternoon. If you have a question that you'd like an answer to, please add it to this thread. Kole or any of your aliases and most other shorts, I have you on ignore, so don't even bother sending a response.
PHARMAHERO is connected to a hedge fund that shorts / scares / manipulates ... As usual, SEC is dumb to catch these manipulators. Positively, it also provides a chance to add more shares on the cheap
You are right of course that PHARMAHERO's posts are always negative, but on the morning after approval it was more like he had advance knowledge. Leerink had released a positive note pre-market and the stock was trading higher. Then PHARMAHERO posted much more specifically than usual that Leerink was only trying to get ther clients out.
My questions so far are:
1. Why would insiders sell their shares at less than $30, if they won't take less than $30 for a buyout? I already know what he is going to say to this, but I'm going to ask it anyway.
2. I would like to know if the length of the halt on the 26th had anything to do with making sure that insider sales went through before the announcement.
3. Reason for making patent app '520 special?
Weren't all insider sales on the 27th? I believe all transactions with the 26th date were coded "A". Acquired shares through option conversion. All expected price to RISE.
I like #3. Thanks for asking.
Apart jokes, could you ask what below in some other manner?
Here's the naive way:
If(and we are confident) there are more than one buyer on horizon, wouldn't be wise (in both company and shareholders' interest) releasing the classic news "AMRN rejects a xx $ offer from xx Company"? Even the lower one. Wouldn't it be a wall to this downside speculation which can itself damage somehow the image of AMRN if we - and also BOD of course - look for a bid war?
Release first offerer, say something.